DNP Select Income Fund Inc. (NYSE:DNP – Get Free Report) CEO David D. Jr. Grumhaus purchased 2,000 shares of the business’s stock in a transaction dated Tuesday, November 26th. The shares were purchased at an average cost of $9.60 per share, with a total value of $19,200.00. Following the completion of the purchase, the chief executive officer now directly owns 8,361 shares in the company, valued at approximately $80,265.60. This represents a 31.44 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
DNP Select Income Fund Stock Up 0.5 %
Shares of DNP traded up $0.05 during midday trading on Wednesday, reaching $9.65. 335,087 shares of the stock were exchanged, compared to its average volume of 652,916. DNP Select Income Fund Inc. has a 12-month low of $8.02 and a 12-month high of $10.04. The firm has a 50 day simple moving average of $9.60 and a 200-day simple moving average of $9.09.
DNP Select Income Fund Dividend Announcement
The company also recently declared a dividend, which was paid on Tuesday, November 12th. Stockholders of record on Friday, November 1st were paid a dividend of $0.065 per share. This represents a dividend yield of 8.15%. The ex-dividend date was Thursday, October 31st.
Institutional Investors Weigh In On DNP Select Income Fund
DNP Select Income Fund Company Profile
DNP Select Income Fund Inc is a closed ended balanced mutual fund launched by Virtus Investment Partners, Inc The fund is managed by Duff & Phelps Investment Management Co It invests in the public equity and fixed income markets of the United States. For the fixed income portion, the fund invests in bonds.
Recommended Stories
- Five stocks we like better than DNP Select Income Fund
- What Are Growth Stocks and Investing in Them
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Why Invest in High-Yield Dividend Stocks?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Nasdaq? Complete Overview with History
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for DNP Select Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DNP Select Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.